An Act relative to APOL1 mediated kidney disease
Take action
Take a stance or write a position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill addresses a specific type of kidney disease linked to a gene called APOL1. It aims to understand and potentially mitigate the risk of end-stage renal disease associated with this genetic condition. The legislation supports a study to further investigate APOL1-mediated kidney disease and its impact on public health. It seeks to improve the understanding and management of this rare but serious illness.
Key provisions
- Authorizes a study to investigate APOL1-mediated kidney disease.
- Focuses on understanding the genetic factors contributing to end-stage renal disease.
- Aims to improve the diagnosis and treatment of affected individuals.
- Supports research into potential preventative measures.
Who is affected
- Individuals at risk of developing APOL1-mediated kidney disease.
- Patients with end-stage renal disease.
- Families affected by kidney disease.
- Researchers and healthcare professionals involved in nephrology.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
5 on record
Primary sponsor
Homar Gómez
Cosponsors
Homar Gómez
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours